Zhang, C., Lu, X., Huang, J., He, H., Chen, L., Liu, Y., . . . Xu, D. (2021). Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma. Wiley.
Chicago Style (17th ed.) CitationZhang, Chuanjie, et al. Epigenome Screening Highlights That JMJD6 Confers an Epigenetic Vulnerability and Mediates Sunitinib Sensitivity in Renal Cell Carcinoma. Wiley, 2021.
MLA (8th ed.) CitationZhang, Chuanjie, et al. Epigenome Screening Highlights That JMJD6 Confers an Epigenetic Vulnerability and Mediates Sunitinib Sensitivity in Renal Cell Carcinoma. Wiley, 2021.
Warning: These citations may not always be 100% accurate.